8:10am ET
Health and Healthcare
Short Sellers Become More Selective on Leading Biotechs
The October 15 short interest data have been compared with the previous figures, and short interest mixed in these selected biotech stocks.
Companies
Alexion Pharmaceuticals, Inc.
$182.50
â–² $0.00 (+0.00%) today
Markets open · 4:09pm ET
ALXN Coverage
Page 1510:05am ET
Health and Healthcare
Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now
Cowen says the way to play biotech is with large cap sector leaders that can beat earnings estimates. It also thinks third-quarter earnings beats could highlight the risk of not owning biotech…
8:20am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The September 30 short interest data have been compared with the previous figures, and short interest increased in most of these selected biotech stocks for this settlement date.
8:40am ET
Health and Healthcare
Why Merrill Lynch Now Favors Large Cap Leaders in Biotech
These four top large cap biotechs are very good bets for investors looking to add high-quality companies with less volatility and binary clinical data risk.
9:25am ET
Health and Healthcare
How the Top Biotechs Handled the Valuation Shock
24/7 Wall St. has taken a look at some of the largest biotech companies and highlighted the damage that a single tweet did to them last week.
8:05am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotech
The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks increased across the board for this settlement date.
9:55am ET
Health and Healthcare
Why Oppenheimer Says Alexion Is a Cheap Buy Now
Oppenheimer maintained its Outperform rating for Alexion Pharmaceuticals with a price target that implies upside of more than 40%.
Chris Lange 8:55am ET
Investing
Top Analyst Upgrades and Downgrades: AeroVironment, Gold Fields, Marvell, Nokia, Silver Wheaton and Many More
Monday's top analyst upgrades, downgrades and initiations include AeroVironment, Gold Fields, Marvell Technology, Nokia and Silver Wheaton.
8:05am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased across the board for this settlement date.
8:55am ET
Health and Healthcare
Short Sellers Become More Focused in Major Biotechs
The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks.
9:20am ET
Health and Healthcare
JPMorgan Has Favorite Biotech Stocks to Buy for Rest of 2015
In a new research report, JPMorgan highlights its favorite biotech stocks to buy after the second-quarter earnings print.
Lee Jackson 8:55am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech stocks backed off for this period.
8:20am ET
Health and Healthcare
3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming
Merrill Lynch has looked at large cap biotech leaders and how interest rate increases may play a part in stock performance.
8:35am ET
Health and Healthcare
3 Potential Huge Takeover Targets in Biotech
In a new research report, Cowen's well-respected analyst Ken Cacciatore makes a very good case that some huge, high-profile biotech companies could be targeted for buyouts.
7:57am ET
Health and Healthcare
Short Sellers Back Off Major Biotechs
ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or…